Adverse events from topical corticosteroid use in chronic hand eczema — Findings from the Danish Skin CohortCapsule Summary

Autor: Alexander Egeberg, MD, PhD, DMSc, Christoph Schlapbach, MD, PhD, Jeanette Halskou Haugaard, MD, PhD, Lea Nymand, MSc, David Thein, MD, Simon Francis Thomsen, MD, PhD, DMSc, Jacob P. Thyssen, MD, PhD, DMSc

Publikováno v: JAAD International, Vol 14, Iss , Pp 77-83 (2024)

Background: Topical corticosteroids (TCS) are used to treat most patients with chronic hand eczema (CHE), but knowledge about TCS-related adverse events in CHE is limited. Objectives: To investigate patient-reported adverse events to TCS in CHE patie

Externí odkaz: https://doaj.org/article/88554a65a6804a75a040e1f6c8186088

Delay in diagnosis and treatment of patients with psoriasis: a population-based cross-sectional study

Autor: Lea Nymand, Mia-Louise Nielsen, Alexander Egeberg, Simon Francis Thomsen, Jacob Pontoppidan Thyssen

Publikováno v: Nielsen, M-L, Nymand, L K, Thomsen, S F, Thyssen, J P & Egeberg, A 2022, ' Delay in diagnosis and treatment of patients with psoriasis : a population-based cross-sectional study ', British Journal of Dermatology, vol. 187, no. 4, pp. 590-591 . https://doi.org/10.1111/bjd.21594

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a4f380b9f2cf33082f988e9ca17308
https://pubmed.ncbi.nlm.nih.gov/35383889

Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries

Autor: Alexander Egeberg, Nana Aviaaja Lippert Rosenø, David Aagaard, Erik Hillo Lørup, Mia-Louise Nielsen, Lea Nymand, Lars Erik Kristensen, Jacob P. Thyssen, Simon Francis Thomsen, Rene Lindholm Cordtz, Nikolai Loft, Lone Skov, Lars Erik Bryld, Mads Kirchheiner Rasmussen, Pil Højgaard, Salome Kristensen, Lene Dreyer

Publikováno v: Egeberg, A, Rosenø, N A L, Aagaard, D, Lørup, E H, Nielsen, M-L, Nymand, L, Kristensen, L E, Thyssen, J P, Thomsen, S F, Cordtz, R L, Loft, N, Skov, L, Bryld, L E, Rasmussen, M K, Højgaard, P, Kristensen, S & Dreyer, L 2022, ' Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis-A nationwide cohort study from the DANBIO and DERMBIO registries ', Seminars in Arthritis and Rheumatism, vol. 53, 151979 . https://doi.org/10.1016/j.semarthrit.2022.151979
Egeberg, A, Rosenø, N A L, Aagaard, D, Lørup, E H, Nielsen, M-L, Nymand, L, Kristensen, L E, Thyssen, J P, Thomsen, S F, Cordtz, R L, Loft, N, Skov, L, Bryld, L E, Rasmussen, M K, Højgaard, P, Kristensen, S & Dreyer, L 2022, ' Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis-A nationwide cohort study from the DANBIO and DERMBIO registries ', Seminars in Arthritis and Rheumatism, vol. 53, pp. 151979 . https://doi.org/10.1016/j.semarthrit.2022.151979
Egeberg, A, Rosenø, N A L, Aagaard, D, Lørup, E H, Nielsen, M L, Nymand, L, Kristensen, L E, Thyssen, J P, Thomsen, S F, Cordtz, R L, Loft, N, Skov, L, Bryld, L E, Rasmussen, M K, Højgaard, P, Kristensen, S & Dreyer, L 2022, ' Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis-A nationwide cohort study from the DANBIO and DERMBIO registries ', Seminars in Arthritis and Rheumatism, vol. 53, 151979 . https://doi.org/10.1016/j.semarthrit.2022.151979

OBJECTIVE: Drug survival is an important proxy measure for effectiveness of treatments for inflammatory diseases such as rheumatoid arthritis (RA), axial spondyloarthritis (AxSpA), psoriatic arthritis (PsA), and psoriasis. The objective of this study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c027781d394f5dcaf784ece9841db344
https://pubmed.ncbi.nlm.nih.gov/35183936